News

Alternate TextBack

BIOLOGICALS & BIOSIMILARS MANUFACTURING FACILITY TO EGYPT

Pharmadule Morimatsu will deliver a modular turn-key facility to Egyptian International Pharmaceutical Industries, EIPICO, for a biological & biosimilar manufacturing facility in Tenth of Ramadan City, Egypt.

The project & commercial team members of EIPICO, Pharmadule Morimatsu and United Group.



The EIPICO 3 facility will be first and largest factory in Egypt and the Middle East to produce biologicals and biosimilars alternatives and medicines in the 10th of Ramadan City with an area of 10.000 sqm. EIPICO 3 will manufacture biological products, monoclonal antibodies (mAbs) and biopharmaceutical proteins.

hexagon

This website uses cookiesfor statistics and user experience.

This website uses cookies to improve your user experience, to provide a basis for improvement and further development of the website and to be able to direct more relevant offers to you.

Feel free to read ours privacy policy. If you agree to our use, choose Accept all. If you want to change your choice afterwards, you will find that option at the bottom of the page.

Cookies